Pharmaceuticals

Plasma Fractionation Market 2026 unlocking new growth opportunities

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Plasma Fractionation Market Over The Period 2026–2030?

The plasma fractionation market has seen rapid growth in recent years. It is projected to increase from $34.14 billion in 2025 to $37.63 billion in 2026, at a compound annual growth rate (CAGR) of 10.2%. This historical growth can be attributed to factors such as a rise in demand for immunoglobulins, an increased prevalence of hematological disorders, continuous technological advancements in plasma fractionation, the expansion of hospital and clinical infrastructure, and a heightened awareness about plasma-derived therapies.

The plasma fractionation market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $55.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this growth during the forecast period include the increasing adoption of precision medicine, the integration of AI into plasma manufacturing, the expansion of global biopharmaceutical collaborations, rising investments in plasma collection centers, and the development of new plasma-derived therapies. Key trends expected during this period involve advanced plasma fractionation techniques, diversification of biopharmaceutical products, improved quality control and regulatory compliance, the expansion of contract manufacturing organizations (CMOs/CDMOs), and optimization of the supply chain for plasma products.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Major Factors Are Driving The Expansion Of The Plasma Fractionation Market?

The escalating prevalence of chronic diseases is anticipated to drive the expansion of the plasma fractionation market moving forward. These conditions, defined as lasting 1 year or longer and requiring ongoing medical attention, include examples such as heart disease, cancer, and diabetes. Providing chronic disease patients with access to plasma products helps reduce morbidity, enhance their quality of life, and offers a cost-effective solution, which will subsequently elevate the demand for plasma fractionation. For instance, in March 2025, GOV.UK, a UK-based non-profit government organization, reported that the prevalence of type 2 diabetes among adults aged 17 and over in England, as recorded by GPs, reached 7.0% in March 2024, an increase from 6.8% in March 2023. Thus, a rising number of chronic diseases across all age groups is expected to propel the growth of the plasma fractionation market.

How Is The Plasma Fractionation Market Divided Into Its Major Segments?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

How Are Trends Transforming The Plasma Fractionation Market Landscape?

Key companies operating within the sector are implementing innovative technologies, including high-tech facility processes that transform donated human plasma into essential medicines, employing advanced methods to make the procedure more efficient and secure. For example, in March 2023, CSL Behring, a company based in Germany, launched a new $470 million plasma fractionation facility. This plant utilizes cutting-edge technology to enhance the efficiency and safety of plasma processing, resulting in higher quality and more reliable medications. By expanding the availability of these vital medicines, the facility contributes to meeting the increasing demand, thereby ensuring greater patient access to life-saving therapies. Its sophisticated automation and self-cleaning systems help to mitigate contamination risks and improve overall sanitary conditions, thus bolstering patient safety.

Who Are The Prominent Organizations Shaping The Plasma Fractionation Market?

Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Read the full plasma fractionation market report here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Region Currently Holds The Largest Share Of The Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plasma Fractionation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Browse Through More Reports Similar to the Global Plasma Fractionation Market 2026, By The Business Research Company

Plasma Fractionation Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Plasma Powder Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Blood Plasma Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795